Search
Menu
Home
HTB
2020
January
HTB
January 2020
Contents
Editorial
HTB 29 January 2020 online
Supplements
i-Base guide to HIV testing and sexual transmission (January 2020)
Antiretrovirals
FDA decision on long-acting cabotegravir/rilpivirine (Cabenuva, Vocabria) injections delayed due to scale-up manufacturing problems
Fostemsavir submitted to EMA for treating multidrug resistant HIV
Gilead announces licensing agreement for Rockefeller University bNAbs
PK and drug interactions
Updates to Liverpool University drug interactions website
Guidelines
US HIV Guidelines updated (December 2019)
BHIVA 2019 audit shows early access to ART but U=U and peer support both need to be improved
Vaccines and microbicides
FluAGE study supports BHIVA recommendations for HIV positive people to have annual flu shot
PDFs
29 January 2020 vol 21 no 1
HTB RSS
Early access
Early phase 1 HIV vaccine study launched in the US and South Africa
21 September 2023
High rates of re-suppression with dolutegravir in the ADVANCE study
19 September 2023
EU approves cabotegravir as injectable PrEP
19 September 2023
Altered kidney function associated with alcohol and cannabis use by women living with HIV
13 September 2023
All early access reports
Current issues
September 2023
August 2023
June 2023
Back issues
Special report
Latest statistics on HIV in the UK: data for 2021
1 December 2022
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage